Vanda Pharmaceuticals Insider Trades
NASDAQ: VNDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 6 · $2.82M
- Shares bought / sold
- 0 / 344.34K
- Net activity
- Net selling $2.8 million
Vanda Pharmaceuticals insider activity
Over the last 12 months, Vanda Pharmaceuticals insiders reported 20 transactions on SEC Form 4: 0 open-market purchases and 6 sales. Insiders bought $0 and sold $2.8 million worth of stock, for net insider selling of $2.8 million. The largest seller was Polymeropoulos Mihael Hristos, with $1.3 million in reported sales.
The most recent filing shows McGuire Daniel Patrick (SVP, GC and Secretary) reporting a transaction in 80,000 shares on Jun 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VNDA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VNDA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | Mitchell Stephen RayDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Honore TageDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | DUGAN RICHARD WDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Duncan Charles CliffDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Chrousos PhaedraDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Ward Anne SempowskiDirector | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | McGuire Daniel PatrickSVP, GC and Secretary | Award | 80,000 | — | Form 4 |
| May 18, 2026 | Mitchell Stephen RayDirector | Gift | 25,836 | — | Form 4 |
| Apr 22, 2026 | Duncan Charles CliffDirector | Award | 57,101 | — | Form 4 |
| Mar 2, 2026 | Birznieks GuntherSVP, Business Development | Sale | 42,431 | $350.73K | Form 4 |
| Mar 2, 2026 | Polymeropoulos Mihael HristosPresident and CEO | Sale | 156,235 | $1.28M | Form 4 |
| Mar 2, 2026 | Wijkstrom JoakimSVP, Chief Marketing Officer | Sale | 30,800 | $254.59K | Form 4 |
| Mar 2, 2026 | Moran Kevin PatrickSVP, CFO & Treasurer | Sale | 42,442 | $350.82K | Form 4 |
| Mar 2, 2026 | Williams TimothySVP & General Counsel | Sale | 42,434 | $350.76K | Form 4 |
| Feb 23, 2026 | Honore TageDirector | Sale | 30,000 | $240.90K | Form 4 |
| Feb 18, 2026 | Moran Kevin PatrickSVP, CFO & Treasurer | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Williams TimothySVP & General Counsel | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Birznieks GuntherSVP, Business Development | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Polymeropoulos Mihael HristosPresident and CEO | Award | 525,000 | — | Form 4 |
| Feb 18, 2026 | Wijkstrom JoakimSVP, Chief Marketing Officer | Award | 125,000 | — | Form 4 |
| Aug 7, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 10,000 | $41.50K | Form 4 |
| Jun 13, 2025 | Mitchell Stephen RayDirector | Sale | 7,000 | $32.13K | Form 4 |
| Jun 5, 2025 | Ward Anne SempowskiDirector | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Honore TageDirector | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | DUGAN RICHARD WDirector | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Chrousos PhaedraDirector | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Mitchell Stephen RayDirector | Award | 59,225 | — | Form 4 |
| May 21, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 481 | $2.11K | Form 4 |
| May 21, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 9,519 | $41.88K | Form 4 |
| May 16, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 20,000 | $84.47K | Form 4 |
| Mar 6, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $25.05K | Form 4 |
| Mar 6, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $25.10K | Form 4 |
| Mar 5, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $25.15K | Form 4 |
| Mar 5, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $25.05K | Form 4 |
| Mar 3, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 10,000 | $47.05K | Form 4 |
| Mar 1, 2025 | Williams TimothySVP & General Counsel | Tax withholding | 26,941 | $128.24K | Form 4 |
| Mar 1, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Tax withholding | 95,999 | $456.96K | Form 4 |
| Mar 1, 2025 | Wijkstrom JoakimSVP, Chief Marketing Officer | Tax withholding | 15,520 | $73.88K | Form 4 |
| Mar 1, 2025 | Moran Kevin PatrickSVP, CFO & Treasurer | Tax withholding | 26,941 | $128.24K | Form 4 |
| Mar 1, 2025 | Birznieks GuntherSVP, Business Development | Tax withholding | 26,941 | $128.24K | Form 4 |
| Feb 28, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 10,000 | $47.60K | Form 4 |
| Feb 27, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 10,000 | $47.60K | Form 4 |
| Feb 26, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $23.90K | Form 4 |
| Feb 26, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 5,000 | $23.75K | Form 4 |
| Feb 25, 2025 | Polymeropoulos Mihael HristosPresident and CEO | Buy | 10,000 | $44.64K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4